Muscle, skin and gastrointestinal problems cause a quarter of patients with heart disease and strokes to stop treatment in HPS2-THRIVE trial

The largest randomised study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment.  Results from the study, including the reasons patients stopped the study treatment, were just published in the EHJ.  Read more Topics: Cardiovascular Disease Prevention - Risk Assessment and Management
Source: ESC News and Press - Category: Cardiology Source Type: news